Camphor
CARDIOVASCULAR SYSTEM
Also known as: 2-Bornanone, 2-Camphanone, alphanon, borneo camphor, camphor (natural), camphor (synthetic), camphor, (+/-)-, camphor, (synthetic), camphora, DL-Camphor, root bark oil
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Camphor is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including ache and Trpa1. Recorded indications include Arthritic Pain, Backache and Sprains and Strains.
- Molecular targets: ache and Trpa1 (2 listed in DrugCentral).
- Indications: Arthritic Pain, Backache and Sprains and Strains.
- ATC code: C01EB02 (Other cardiac preparations).
- Molecular formula: C10H16O; molecular weight 152.24 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (3)
- Arthritic Pain
- Backache
- Sprains and Strains
Contraindications (30)
- Anemia
- Anemia due to enzyme deficiency
- Blister
- Blood coagulation disorder
- Body fluid retention
- Breastfeeding (mother)
- Cardiovascular event risk
- Condyloma acuminatum
- Denuded skin
- Diabetes mellitus
- Disease of liver
- Disorder of cardiovascular system
- Disorder of skin
- Factor II deficiency
- Gastritis
- Gastroesophageal reflux disease
- Gastrointestinal hemorrhage
- Gastrointestinal ulcer
- Hemophilia
- Hepatic failure
- Infection of skin AND/OR subcutaneous tissue
- Inflammatory dermatosis
- Kidney disease
- Nasal polyp
- Peripheral vascular disease
- Pregnancy, function
- Skin irritation
- Thrombotic thrombocytopenic purpura
- Thyrotoxicosis
- Vitamin K deficiency
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Acetylcholinesterase | ache | unknown | Ki 4.30 |
| Transient receptor potential cation channel subfamily A member 1 | Trpa1 | other | IC50 4.20 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C01EB02 | CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › OTHER CARDIAC PREPARATIONS › Other cardiac preparations |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Methaemoglobinaemia | 352.3 |
| Joint dislocation | 219.8 |
| Seronegative arthritis | 161.1 |
| Joint stiffness | 160.3 |
| Prescribed underdose | 152.3 |
| Lupus vulgaris | 118.5 |
| Hypercholesterolaemia | 118.4 |
| Wound infection | 111.2 |
| Walking aid user | 110.7 |
| Retinitis | 110.4 |
| Laryngitis | 110.0 |
| Type 2 diabetes mellitus | 105.8 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Camphor is on its molecule page.
| Molecular formula | C10H16O |
|---|---|
| Molecular weight | 152.24 g/mol |
| CAS number | 76-22-2 |
| InChIKey | DSSYKIVIOFKYAU-UHFFFAOYSA-N |
| PubChem CID | 2537 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Camphor used for?
DrugCentral lists the following indications for Camphor: Arthritic Pain, Backache and Sprains and Strains.
How does Camphor work?
Its molecular targets in DrugCentral include ache and Trpa1.
What is the chemical formula of Camphor?
Camphor has the molecular formula C10H16O and a molecular weight of 152.24 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 470 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL15768 — compound record and bioactivity
- PubChem CID 2537 — chemical identifiers
- DrugBank DB01744 — drug record
- FDA UNII 5TJD82A1ET — substance identity
- DailyMed: FDA labels for Camphor — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.